# Psilocybin-Assisted Psychotherapy in Patients With Advanced Cancer on Maintenance Therapy

> **NCT06200155** · PHASE2 · RECRUITING · sponsor: **M.D. Anderson Cancer Center** · enrollment: 30 (estimated)

## Conditions studied

- Depression, Anxiety
- Psilocybin-Assisted Psychotherapy
- Advanced Cancer

## Interventions

- **DRUG:** Psilocybin
- **OTHER:** Niacin

## Key facts

- **NCT ID:** NCT06200155
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-04-16
- **Primary completion:** 2026-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2026-04-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06200155

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06200155, "Psilocybin-Assisted Psychotherapy in Patients With Advanced Cancer on Maintenance Therapy". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06200155. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*